Compounding pharmacy regulations: experience of the North American pharmaceutical market-Reference-Cited by-同舟云学术

Compounding pharmacy regulations: experience of the North American pharmaceutical market

Published:2023-04-21 Issue:1 Volume:16 Page:80-86
ISSN:2070-4933
Container-title:FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
language:
Short-container-title:Farmakoèkonomika

Author:

Mamedov D. D.¹^ORCID,Yurochkin D. S.¹^ORCID,Leshkevich A. A.¹^ORCID,Erdni-Garyaev S. E.¹^ORCID,Golant Z. M.¹^ORCID,Narkevich I. A.¹^ORCID

Affiliation:

1. Saint Petersburg State Chemical Pharmaceutical University

Abstract

In order to improve regulation of socially significant type of activity in the field of compounding pharmacy production, the review summarizes the technological, organizational and regulatory requirements for ensuring quality and safety of compounding drugs, as well as historical and technical analysis of the compounding pharmacy regulation in North American pharmaceutical market. The main imperatives are identified and the best practices recommended for implementation into the current state of the pharmaceutical market in the Russian Federation.

Publisher

IRBIS

Subject

Public Health, Environmental and Occupational Health,Health Policy,Pharmacology

Reference10 articles.

1. Global Market Insights. Compounding Pharmacies Market 2022. Available at: https://www.gminsights.com/industry-analysis/compounding-pharmacies-market (accessed 28.09.2022).

2. U.S. Food and Drug Administration Section 503A of the Federal Food, Drug, and Cosmetic Act. Available at: https://www.fda.gov/drugs/human-drug-compounding/section-503a-federal-food-drug-and-cosmetic-act (accessed 28.09.2022).

3. Barlas S. Two draft FDA guidance documents stir controversy. PT. 2015; 40 (9): 569.

4. U.S. Food and Drug Administration. Pharmacy Compounding Advisory Committee. Federal Register Vol. 79, No. 8. Available at: http://www.gpo.gov/fdsys/pkg/FR-2014-01-13/pdf/2014-00322.pdf (accessed 28.09.2022).

5. Bonner L. FDA continues to release compounding guidance. Pharmacy Today. 2015; 21 (3): 78.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Compounding pharmacy regulations: experience of the Latvian pharmaceutical market;FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology;2024-05-03

2. Pharmacy Compounding Regulation in the German Pharmaceutical Market. Part 1. Basic Regulatory Provisions (Review);Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. Regulatory Research and Medicine Evaluation;2024-02-29

3. Past, current and future of legal regulation of drugs compounding in the Russian Federation;Pharmacy & Pharmacology;2023-11-21

4. Pharmaceutical compounding in Russia: analysis of open competitive procurement and segment prospects;Medical Technologies. Assessment and Choice;2023